Neumora Therapeutics, Inc.
NMRA
$1.28
-$0.12-8.57%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 6.21% | 5.41% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -17.91% | 20.09% | |||
Operating Income | 17.91% | -20.09% | |||
Income Before Tax | 18.86% | -23.76% | |||
Income Tax Expenses | -100.00% | -57.60% | |||
Earnings from Continuing Operations | 18.92% | -23.59% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 18.92% | -23.59% | |||
EBIT | 17.91% | -20.09% | |||
EBITDA | 17.94% | -20.15% | |||
EPS Basic | 19.62% | -23.13% | |||
Normalized Basic EPS | 19.55% | -23.27% | |||
EPS Diluted | 19.62% | -23.13% | |||
Normalized Diluted EPS | 19.55% | -23.27% | |||
Average Basic Shares Outstanding | 0.88% | 0.37% | |||
Average Diluted Shares Outstanding | 0.88% | 0.37% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |